跳至主要内容
临床试验/NCT04892615
NCT04892615尚未招募不适用

The Safety Research of Timing of the Removal of Abdominal Drains After Pancreatic Surgery : Results of a Prospective Randomized Clinical Trial

Xian-Jun Yu1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
114
试验地点
1
主要终点
The incidence of postoperative pancreatic fistula and abdominal infection;

研究概览

简要总结

Randomized, open, single-center, controlled prospective studies were designed to obtain reliable level I evidence in evidence-based medicine.Based on the premise of at least a 6-fold reduction in pancreatic fistula, as observed by Kawai et al after early drainage.Considering the overall incidence of pancreatic fistula after standard pancreatectomy at our center (approximately 20%), we would expect this complication to occur in approximately 3.4% of cases in Group A.α was set as 0.05 and β was set as 0.2 (efficacy was 80%), indicating that the total number of study subjects was at least 114 patients (at least 57 patients in the experimental group and 57 patients in the control group).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ECOG 0-2;
  • The amylase value in the drainage tube of patients receiving pancreaticoduodenectomy or distal pancreatectomy was lower than 5000 IU/L on the first day after surgery;
  • postoperative drainage tube placement;
  • Patients with no obvious contraindication to surgery;
  • Expected postoperative survival ≥3 months;

排除标准

  • Pancreaticoduodenectomy and pancreaticogastric anastomosis were performed;
  • Suspicion or abdominal bleeding within 5 days after surgery;
  • suspected biliary and intestinal fistula within 5 days after operation;
  • On the fifth day after the operation, abdominal CT reexamination showed local effusion with a depth greater than 3cm.

结局指标

主要结局

The incidence of postoperative pancreatic fistula and abdominal infection;

时间窗: 3month

Severity of complications (duration of postoperative hospital stay) was assessed by Dindo Clavien classification.

时间窗: 3month

次要结局

未报告次要终点

研究者

发起方
Xian-Jun Yu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Xian-Jun Yu

President of Pancreatic Cancer Institute

Fudan University

研究点 (1)

Loading locations...

相似试验